Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a clinical-stage cancer immunotherapy company dedicated to the discovery and development of novel myeloid checkpoint inhibitors for cancer patients. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies.

Therapeutics

Pharmaceutical

Biotechnology

Immune-Onc Therapeutics

Immune-Onc Therapeutics' headquarters in Palo Alto, CA, United States

Charlene Liao

Helen Y.

Hong Xiang

Maggie Gu

Chengcheng Zhang

Feng Deng

Liqun Luo

Michael Karin

Zhiqiang An

Austin Gurney

Jack Donahue

Guo-Liang Yu

Dave Chenn

Greg Cosma

Barbara Klencke

The Directors Team at Immune-Onc Therapeutics is responsible for strategic decision-making and overseeing various aspects of the company's operations. This includes guiding clinical development, preclinical research, bioanalytical assessments, and overall project management to ensure the successful advancement of novel myeloid checkpoint inhibitors through the drug development pipeline. They collaborate closely to align the company's scientific, clinical, and business objectives.

Directors Team

The Scientific and Clinical Team at Immune-Onc Therapeutics is responsible for spearheading the discovery and development of novel myeloid checkpoint inhibitors. This team merges extensive scientific research with clinical expertise to advance innovative cancer immunotherapies through rigorous preclinical and clinical trials, ensuring both efficacy and safety in treating cancer patients.

Scientific and Clinical Team

The Leadership Team at Immune-Onc Therapeutics is responsible for setting the strategic vision and direction of the company, overseeing its clinical development programs, and fostering innovation in cancer immunotherapy. Comprised of visionary founders and experienced biotechnology leaders, the team drives collaboration among various departments, ensures alignment with the company's mission, and engages with stakeholders to effectively advance groundbreaking myeloid checkpoint inhibitors for cancer treatment.

Leadership Team

Immune-Onc Therapeutics

Org chart

Board & advisors

Teams

Directors Team

Scientific and Clinical Team

Leadership Team

Offices

Immune-Onc Therapeutics

Org chart

Board & advisors

Teams

Directors Team

Scientific and Clinical Team

Leadership Team

Offices

Related companies